Recent presentations and scientific papers. Presentations are in Adobe Acrobat format unless otherwise noted.

Scientific Presentations

High Rate of Sustained Virologic Response in Patients with HCV Genotype-1A Infection: A Phase 2 Trial of Faldaprevir, Deleobuvir and PPI-668, with and without Ribavirin (EASL, April 2014)

PPI-668, A Potent New Pan-Genotypic HCV NS5A Inhibitor: Phase 1 Efficacy and Safety (AASLD, November 2012)